Inclusion criteria for subjects to be shifted from Study A0081107
- Subjects who completed the 18-week study period in Study A0081107 conducted for
chronic neuropathic pain after spinal cord injury;
- Subjects who completed assessments of all efficacy endpoints until the end of the
treatment phase of the preceding Study A0081107 (V7);
Inclusion criteria for subjects to be new participants in this study
- Subjects with central neuropathic pain after stroke or multiple sclerosis;
- At least 6 months have passed after the onset of central neuropathic pain;
- Pain VAS at least 40mm in Visit 1 and Visit 2;
- Creatinine clearance
- Platelet count count
- Subjects who are expected to require surgery during the trial;